Matches in Wikidata for { <http://www.wikidata.org/entity/Q98203978> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q98203978 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98203978 description "scientific article published on 05 August 2020" @default.
- Q98203978 description "wetenschappelijk artikel" @default.
- Q98203978 description "наукова стаття, опублікована 5 серпня 2020" @default.
- Q98203978 name "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 name "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 type Item @default.
- Q98203978 label "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 label "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 prefLabel "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 prefLabel "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 P1433 Q98203978-E57A59B0-CEC1-40EF-A0F5-533EDBA7E271 @default.
- Q98203978 P1476 Q98203978-8C51E511-A522-4A29-A253-E0D98D8A13A7 @default.
- Q98203978 P2093 Q98203978-10A3EC5C-3AD8-448F-8AAD-250D2729EE53 @default.
- Q98203978 P2093 Q98203978-20407611-F252-40E6-B4A6-4E02938D3EAE @default.
- Q98203978 P2093 Q98203978-542D05A2-CFB8-470E-96CC-7AA5D90AB17B @default.
- Q98203978 P2093 Q98203978-60FC3FCA-827A-4B6B-BD59-5448804EEF3D @default.
- Q98203978 P2093 Q98203978-D8F648A3-F911-4B1A-BA97-29CFC17ABB7F @default.
- Q98203978 P2093 Q98203978-F6412B08-448F-49AC-9591-09776D887396 @default.
- Q98203978 P2860 Q98203978-54AD9A7D-AEB8-461D-8F8C-C016C7606760 @default.
- Q98203978 P304 Q98203978-DD144670-00A1-4EA5-BD78-6F4A772D70B9 @default.
- Q98203978 P31 Q98203978-F4FC4571-D0BA-4ADD-840A-81E21ACD43F8 @default.
- Q98203978 P356 Q98203978-080FE0C9-9C54-488B-9DA8-66B0E5C0B65E @default.
- Q98203978 P577 Q98203978-3C0C7450-B42D-4216-A98D-E37AF38897EF @default.
- Q98203978 P698 Q98203978-616D1FF6-F074-4CF8-87BD-A8E3D9570976 @default.
- Q98203978 P921 Q98203978-3937A6E4-9F62-45EE-9E6D-63FF0BD2AA0D @default.
- Q98203978 P356 07391102.2020.1802346 @default.
- Q98203978 P698 32752938 @default.
- Q98203978 P1433 Q15754747 @default.
- Q98203978 P1476 "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials" @default.
- Q98203978 P2093 "Alper Okyar" @default.
- Q98203978 P2093 "Ibrahim Barıs" @default.
- Q98203978 P2093 "Ibrahim Halil Kavakli" @default.
- Q98203978 P2093 "Onur Ozcan" @default.
- Q98203978 P2093 "Seref Gul" @default.
- Q98203978 P2093 "Sinan Asar" @default.
- Q98203978 P2860 Q31153826 @default.
- Q98203978 P304 "1-20" @default.
- Q98203978 P31 Q13442814 @default.
- Q98203978 P356 "10.1080/07391102.2020.1802346" @default.
- Q98203978 P577 "2020-08-05T00:00:00Z" @default.
- Q98203978 P698 "32752938" @default.
- Q98203978 P921 Q82069695 @default.